Clinical Trial Update: Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 study assessing safety and efficacy of PB-201 in treatment-naive adults with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PB-201

Snippet

Sponsor: PegBio Co., Ltd. | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 3 | Status: UNKNOWN